You Position: Home > Paper

Cost-effectiveness analysis of 3 different drugs in the treatment of type 2 diabetes mellitus

( views:219, downloads:32 )
Author:
No author available
Journal Title:
Chinese Journal of Primary Medicine and Pharmacy
Issue:
3
DOI:
10.3760/cma.j.issn.1008-6706.2012.03.018
Key Word:
糖尿病,2型;临床方案;费用,药物;Diabetes mellitus,type 2;Clinical protocols;Fees,pharmaceutical

Abstract: Objective To analyze the cost-effectiveness of the treatment of type 2 diabetes by 3 different drugs.Methods Through the retrospective analysis of 198 cases with T2DM and drug economics,to analyze the costeffectiveness of the Yamo Li(glimepiride),repaglinide(repaglinide) and Avandia(rosiglitazone).Results No significant difference was observed in the total effective rate among the 3 drugs.The cost-effectiveness ratios in Group A,B and C were 2.99,1.43 and 5.76.The cost-effectiveness ratios increments in Group A,B and C were 42.15,18.32 and 214.74.Conclusion Based on individual differences of the patients,doctor should choose the drug with best treatment,lowest price and highest safety.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn